Key facts
- It has raised $10.0M; the latest was Later Stage VC ($10.0M) in Jan 2026.
- Notable investors include Exceptional Ventures, Cross Road Biotech, Futura SGR, Lumen Ventures (Rome), P101.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Carol
- ·The full record, as it builds
Funding rounds
No funding rounds for Carol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Carol
Developer of a virtual primary care service platform designed to offer digital health services. The company's platform provides services such as access to doctors, a team of dedicated doctors, consultation for common illnesses and injuries, prescriptions for medications, lab test referrals, mental health support, and chronic disease management, enabling patients to access doctors anytime, anywhere from their mobile phones.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 2022
- Employees
- 25
- Website
- carol.health/
- Ownership
- Privately Held (backing)
Carol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Carol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Carol in its N-PORT filings yet. We sweep new filings monthly.